These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 22462676)

  • 21. The immunobiology of Guillain-Barré syndromes.
    Willison HJ
    J Peripher Nerv Syst; 2005 Jun; 10(2):94-112. PubMed ID: 15958123
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiganglioside antibodies in Guillain-Barré syndrome and its related conditions.
    Shahrizaila N; Yuki N
    Expert Rev Neurother; 2011 Sep; 11(9):1305-13. PubMed ID: 21864076
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Guillain-Barré syndrome-like-onset neurosarcoidosis positive for immunoglobulin G anti-N-acetylgalactosaminyl-GD1a antibody.
    Chatani H; Tanaka M; Nagata T; Araki T; Kusunoki S
    J Clin Neurosci; 2014 Jan; 21(1):170-2. PubMed ID: 23916762
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GalNAc-GD1a in human peripheral nerve: target sites of anti-ganglioside antibody.
    Kaida K; Kusunoki S; Kamakura K; Motoyoshi K; Kanazawa I
    Neurology; 2003 Aug; 61(4):465-70. PubMed ID: 12939418
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential immune response to gangliosides in Guillain-Barré syndrome patients from Japan and The Netherlands.
    Ang CW; Koga M; Jacobs BC; Yuki N; van der Meché FG; van Doorn PA
    J Neuroimmunol; 2001 Dec; 121(1-2):83-7. PubMed ID: 11730944
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A case of Guillain-Barré syndrome with bulbar palsy showing the elevations of the anti-GD1a and GT1b antibodies].
    Ito S; Hirose Y; Mokuno K; Kusunoki S
    Rinsho Shinkeigaku; 2001; 41(4-5):202-5. PubMed ID: 11676164
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A family with Campylobacter enteritis: anti-GD1a antibody with/without Guillain-Barré syndrome.
    Hirano M; Kusunoki S; Asai H; Tonomura Y; Morita D; Ueno S
    Neurology; 2003 May; 60(10):1719-20. PubMed ID: 12771281
    [No Abstract]   [Full Text] [Related]  

  • 28. Dissecting the Role of Anti-ganglioside Antibodies in Guillain-Barré Syndrome: an Animal Model Approach.
    Asthana P; Vong JS; Kumar G; Chang RC; Zhang G; Sheikh KA; Ma CH
    Mol Neurobiol; 2016 Sep; 53(7):4981-91. PubMed ID: 26374552
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical features of neuropathies in a group of patients associated with anti-GalNAc-GD1a antibody].
    Tatsumoto M; Odaka M; Koga M; Hirata K; Yuki N
    Rinsho Shinkeigaku; 2004 Aug; 44(8):508-12. PubMed ID: 15471085
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ganglioside mimicry and peripheral nerve disease.
    Yuki N
    Muscle Nerve; 2007 Jun; 35(6):691-711. PubMed ID: 17373701
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased plasmacytoid dendritic cells in Guillain-Barré syndrome.
    Wang YZ; Feng XG; Wang Q; Xing CY; Shi QG; Kong QX; Cheng PP; Zhang Y; Hao YL; Yuki N
    J Neuroimmunol; 2015 Jun; 283():1-6. PubMed ID: 26004148
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ganglioside-specific IgG and IgA recruit leukocyte effector functions in Guillain-Barré syndrome.
    van Sorge NM; Yuki N; Koga M; Susuki K; Jansen MD; van Kooten C; Wokke JH; van de Winkel JG; van der Pol WL; van den Berg LH
    J Neuroimmunol; 2007 Jan; 182(1-2):177-84. PubMed ID: 17156858
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibodies to gangliosides and ganglioside complexes in Guillain-Barré syndrome and Fisher syndrome: mini-review.
    Kaida K; Kusunoki S
    J Neuroimmunol; 2010 Jun; 223(1-2):5-12. PubMed ID: 20172612
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A case of Guillain-Barré syndrome after Campylobacter jejuni enterocolitis: anti-ganglioside antibody levels with or without Guillain-Barré syndrome].
    Watanabe H; Shindo K; Nakamura Y; Nagamatsu M; Shiozawa Z; Kusunoki S
    Rinsho Shinkeigaku; 2001 Sep; 41(9):625-7. PubMed ID: 11968750
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nodal proteins are target antigens in Guillain-Barré syndrome.
    Devaux JJ; Odaka M; Yuki N
    J Peripher Nerv Syst; 2012 Mar; 17(1):62-71. PubMed ID: 22462667
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Campylobacter gene polymorphism as a determinant of clinical features of Guillain-Barré syndrome.
    Koga M; Takahashi M; Masuda M; Hirata K; Yuki N
    Neurology; 2005 Nov; 65(9):1376-81. PubMed ID: 16162859
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathogenicity of anti-ganglioside antibodies in the Guillain-Barré syndrome.
    van Sorge NM; van der Pol WL; Jansen MD; van den Berg LH
    Autoimmun Rev; 2004 Feb; 3(2):61-8. PubMed ID: 15003189
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neurophysiological and immunohistochemical studies on Guillain-Barre syndrome with IgG anti-GalNAc-GD1a antibodies-effects on neuromuscular transmission.
    Taguchi K; Ren J; Utsunomiya I; Aoyagi H; Fujita N; Ariga T; Miyatake T; Yoshino H
    J Neurol Sci; 2004 Oct; 225(1-2):91-8. PubMed ID: 15465091
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of anti-gangliosides antibodies and anti-CMV antibodies in Guillain-Barré syndrome.
    Wang L; Shao C; Yang C; Kang X; Zhang G
    Brain Behav; 2017 May; 7(5):e00690. PubMed ID: 28523231
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Campylobacter coli enteritis and Guillain-Barré syndrome: no evidence of molecular mimicry and serological relationship.
    Funakoshi K; Koga M; Takahashi M; Hirata K; Yuki N
    J Neurol Sci; 2006 Jul; 246(1-2):163-8. PubMed ID: 16600306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.